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Aims The long-term prognostic value of coronary computed tomography angiography (CCTA)-identified coronary artery
disease (CAD) has not been evaluated in elderly patients (>_70 years). We compared the ability of coronary CCTA
to predict 5-year mortality in older vs. younger populations.
...................................................................................................................................................................................................
Methods
and results
From the prospective CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational
Multicenter) registry, we analysed CCTA results according to age <70 years (n = 7198) vs. >_70 years (n = 1786).
The severity of CAD was classified according to: (i) maximal stenosis degree per vessel: none, non-obstructive
(1–49%), or obstructive (>50%); (ii) segment involvement score (SIS): number of segments with plaque. Cox-
proportional hazard models assessed the relationship between CCTA findings and time to mortality. At a mean 5.6
± 1.1 year follow-up, CCTA-identified CAD predicted increased mortality compared with patients with a normal
CCTA in both <70 years [non-obstructive hazard ratio (HR) confidence interval (CI): 1.70 (1.19–2.41); one-vessel:
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1.65 (1.03–2.67); two-vessel: 2.24 (1.21–4.15); three-vessel/left main: 4.12 (2.27–7.46), P < 0.001] and >_70 years
[non-obstructive: 1.84 (1.15–2.95); one-vessel: HR (CI): 2.28 (1.37–3.81); two-vessel: 2.36 (1.33–4.19); three-vessel/
left main: 2.41 (1.33–4.36), P = 0.014]. Similarly, SIS was predictive of mortality in both <70 years [SIS 1–3: 1.57
(1.10–2.24); SIS >_4: 2.42 (1.65–3.57), P < 0.001] and >_70 years [SIS 1–3: 1.73 (1.07–2.79); SIS >_4: 2.45 (1.52–3.93),
P < 0.001]. CCTA findings similarly predicted long-term major adverse cardiovascular outcomes (MACE) (all-cause
mortality, myocardial infarction, and late revascularization) in both groups compared with patients with no CAD.
...................................................................................................................................................................................................
Conclusion The presence and extent of CAD is a meaningful stratifier of long-term mortality and MACE in patients aged <70
years and >_70 years old. The presence of obstructive and non-obstructive disease and the burden of atheroscler-
osis determined by SIS remain important predictors of prognosis in older populations.
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Introduction
Coronary artery disease (CAD) remains a leading cause of morbidity
and mortality in older populations.1,2 Coronary computed tomog-
raphy angiography (CCTA)-identified non-obstructive and obstructive
CAD are both associated with increased major adverse cardiovascular
outcomes (MACE) and all-cause mortality.3 Moreover, atherosclerot-
ic disease burden quantified by either an increasing number of
obstructed vessels (single-, double-, triple-vessel, and/or left main) or
by the number of coronary segments manifesting atherosclerotic pla-
que correlate directly with MACE at both medium- and long-term fol-
low-up.4,5 The National Institute for Health and Care Excellences
(NICE) Clinical Guidelines 2016 recommend CCTA as the first-line
test for the evaluation of chest pain in those at risk of CAD.6
However, the use of CCTA in older populations (>_70 years old)
remains contentious given the higher pre-test likelihood of CAD and
increased coronary calcification in this age group, which diminish the
specificity of CCTA.7 Importantly, the incremental prognostic value of
CCTA beyond traditional risk factors in the long-term is uncertain in
this group. We, therefore, aimed to investigate the ability of CCTA
findings to predict long-term (5-year) mortality and MACE in older
populations (over 70 years) independently of clinical risk factors.
Methods
Design overview, setting, and participants
The initial study design and rationale of the CONFIRM (COronary CT
Angiography EvaluatioN For Clinical Outcomes: An InteRnational
Multicenter) registry has been previously described.4 In brief, CONFIRM
is a prospective, multinational observational study of patients undergoing
CCTA, consisting of 27 125 consecutive participants designed to assess
the ability of CCTA findings to predict all-cause mortality in patients
referred for CCTA. Patients included those with suspected but without
known CAD, or asymptomatic people undergoing CAD evaluation.
As part of the long-term follow-up registry, 5-year data were available
for 12 086 participants who underwent CCTA at 17 centres in nine coun-
tries (Austria, Canada, Germany, Israel, Italy, Portugal, South Korea,
Switzerland, and USA) between February 2003 and May 2011. Inclusion
criteria were patients aged 18 years or older without a known history of
CAD and undergoing evaluation by a computed tomography (CT) scan-
ner with 64-detector rows or greater. Patients that underwent early
revascularization within 90 days of CCTA were excluded. Each of the
study sites’ institutional review boards approved the study protocol and
patients provided written informed consent when required.
For the present analysis, the primary endpoint was long-term all-cause
mortality at 5 years, and the secondary outcome was MACE [defined as
all-cause mortality, myocardial infarction, late revascularization (>90 days
post-CCTA), and CAD-related hospitalization] at 5 years. To determine
the validity of CCTA in older populations, the relationship between
CCTA findings and outcomes were assessed according to age groups
(<70 years vs. >_70 years).
Clinical data collection
Clinical data were prospectively collected for each study participant includ-
ing the presence of traditional cardiac risk factors.3 Hypertension was
defined as a documented history of high blood pressure or treatment with
anti-hypertensive medications. Diabetes mellitus was defined as known un-
treated diabetes and/or use of insulin or oral hypoglycaemic agents.
Dyslipidaemia was defined as known but untreated dyslipidaemia or cur-
rent treatment with lipid-lowering medications. A positive smoking history
was defined as current smoking or smoking cessation within 3 months.
Family history of CAD was determined by patient inquiry. Mortality out-
comes were obtained from the National Death Index or otherwise by dir-
ect interview, telephone contact with a patient’s family or primary care
physician, or review of medical records. MACE were ascertained by direct
patient interview, telephone contact, or review of medical records.
Image acquisition and analysis
Image acquisition was performed using a minimum 64-slice CT scanner in
accordance with the Society of Cardiovascular Computed Tomography
Guidelines.8 For CCTA, all identified coronary lesions were examined by
maximum intensity-projection and multiplanar reconstruction methods
along multiple longitudinal axes and in the transverse plane. A modified
American Heart Association (AHA) 16-segment coronary artery model
was adopted for analyses.9 We defined coronary plaque as any tissue
structure larger than 1 mm2, observed in two planes and located either
within the lumen of the coronary artery or adjacent to the coronary ar-
tery lumen that was able to be distinguished from adjacent epicardial fat,
pericardial tissue, or the artery lumen. Coronary artery luminal stenosis
was defined as the presence of any plaque resulting in diameter reduction.
CCTA results were classified on a per-patient and per-vessel level as ei-
ther: ‘normal’ (no detectable plaque), non-obstructive (plaque resulting in
1–49% diameter stenosis), or obstructive (plaque resulting in >50% sten-
osis). Patients with obstructive disease were further classified as either
single, two-, or three-vessel/left main disease. Segment involvement score
2 S.R. Gnanenthiran et al.
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(SIS) was calculated as the number of segments with calcific or non-
calcific plaque irrespective of stenosis severity.
Statistical analysis
Continuous and categorical variables are expressed as mean ± standard
deviation and absolute counts with percentages. Differences between
continuous and categorical variables were analysed by the Student’s t-test
if normally distributed or the Wilcoxon rank-sum test if not normally dis-
tributed. Categorical variables were analysed using v2 test as appropriate.
Cumulative event rates as a function of time and CCTA parameters were
calculated by use of the Kaplan–Meier survival estimates and compared
using the log-rank test. The Kaplan–Meier mortality-free survival was
stratified by the presence, extent, and severity of CAD (obstructive vs.
non-obstructive, number of segments involved) by CCTA in those aged
<70 years compared with those >_70 years old.
Survival analyses using unadjusted and adjusted Cox proportional haz-
ard regression modelling was used to assess the relationship between
study variables and time to mortality, calculated as hazard ratios (HRs)
with 95% confidence intervals (CIs). Prespecified univariables considered
include age and traditional cardiovascular risk factors. Only univariables
with P< 0.10 were entered into the multivariable models. Variables were
assessed to ensure satisfaction of the proportionality assumption. Logistic
regression was used to determine the variables associated with categoric-
al outcomes including all-cause mortality and MACE. Cox regression ana-
lysis was conducted in categories based on the extent of CAD [(i) non-
obstructive, obstructive single-, double-, triple-vessel/left main disease;
and (ii) number of segments involved: 0, 1–3, >_4 segments], stratified by
age <70 vs. >_70 years.
All analyses were performed using SPSS Version 22.0 (IBM Corp.
Released 2013. IBM SPSS Statistics for Windows, Armonk, NY: IBM
Corp.), and a P-value <0.05 was considered significant.
Results
Among 12 086 patients in the long-term CONFIRM registry, 3102
people were excluded due to being lost to follow-up, a known his-
tory of CAD, receiving early revascularization, age not recorded, or
incomplete CCTA results. A total of 8984 people were therefore
included in our analysis (Figure 1) with a mean follow-up of
2057± 411 days (5.6 years). MACE data were available for 4413
participants.
Baseline characteristics are summarized in Table 1. The mean age
of the total cohort was 58± 19 years and 54.5% were male. There
were 7198 people aged <70 years and 1786 people aged >_70 years.
While there was a higher prevalence of diabetes, hypertension, and
dyslipidaemia in the older cohort, male sex, family history, and cur-
rent smoking were more prevalent in those <70 years old (Table 1,
Supplementary data online, Table S1).
CCTA results
CCTA results are presented in Table 2. Among the younger popula-
tion, nearly half had a normal CCTA, and one-quarter had coronary ar-
tery luminal stenosis. Conversely, in the elderly group 16.8% of
patients had a normal CCTA and obstructive disease was seen in near-
ly half of the cohort. While younger people were more likely to have
single vessel disease (15.0% one-vessel, 6.2% two-vessel, and 5.2%
three-vessel disease), there was more multivessel disease involvement
in the older cohort (20.0% one-vessel, 12.0% two-vessel, and 14.2%
three-vessel disease, P< 0.001). Similarly, there was a higher burden of
disease as assessed by SIS in those aged >_70 years (Table 2).
Clinical outcomes
The overall 5-year mortality rate in the younger group was 6.0%
(Table 3), with an overall MACE rate of 16.0% (Supplementary data
online, Table S2). There was an incremental increase in mortality in this
group with increasing degrees of CAD severity as determined by the
presence and extent of obstructive disease and also using SIS (P-value
for trend <0.001) (Table 3, Figure 2A). Interestingly, mortality was simi-
lar in those with one-vessel vs. non-obstructive disease in both adjusted
and unadjusted results (Figure 2A). In the subgroup analysis, there was a
similar association between MACE and the extent of CAD severity on
CCTA (Supplementary data online, Table S3, Figures S1 and S2).
Mortality at 5 years was 24.8% in the older group, with a MACE
rate of 33.6%. While there was an incremental increase in mortality
in this group when stratified by CCTA results (Table 3,
Supplementary data online, Table S2, Figure 2), there was still a high
rate of mortality in elderly patients with normal CCTA results
(15.7%). Incremental SIS appeared to be better at predicting
Figure 1 Patient selection flowchart.
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.mortality than increasing number of vessels with obstructive disease
post-adjustment (Figure 2B and D). In the subgroup analysis, MACE
similarly increased when stratified by CCTA results (Supplementary
data online, Table S3).
CCTA results were predictive of mortality in both the younger and
older cohorts, with incremental prognostic value with increasing
degrees of obstructive disease and SIS in both unadjusted and adjusted
results (Tables 4 and 5). In older populations, the presence of any ob-
structive disease was a predictor of mortality, however, number of
stenosed vessels did not alter prognosis with one-vessel (HR 2.28,
95% CI 1.37–3.81, P= 0.002), two-vessel (HR 2.36, 95% CI 1.33–4.19,
P= 0.003), and three-vessel/left main disease (HR 2.41, 95% CI 1.33–
4.36, P= 0.004) having similar mortality outcomes post-adjustment
(Figure 2B). However, increasing SIS was still able to incrementally dif-
ferentiate mortality outcomes in the elderly (SIS 0: HR 1.00, 1–3: HR
1.73, 95% CI 1.07–2.79, >_4: HR 2.45, 95% CI 1.52–3.93) (Figure 2D).
Similarly, the presence of obstructive disease and increasing SIS on
CCTA was a predictor of mortality in the subset of patients who
....................................................................................................................................................................................................................
Table 1 Baseline clinical characteristics stratified by age groups (long-term cohort)
Overall group
(n5 8984)
<70 years
(n5 7198)
70 years
(n51786)
P-value
Age (years), mean ± SD 58.2 ± 13.2 53.8 ± 10.6 76.1 ± 5.1 <0.001
Male sex, n (%) 4894 (54.5) 4072 (56.6) 822 (46.0) <0.001
Body mass index (kg/m2), mean ± SD 27.2 ± 5.1 27.5 ± 5.2 26.2 ± 4.3 <0.001
Cardiovascular risk factors, n (%)
Diabetes 1501 (16.7) 1151 (16.0) 350 (19.7) <0.001
Dyslipidaemia 4698 (52.4) 3723 (51.8) 975 (54.7) 0.015
Hypertension 4779 (53.2) 3636 (50.6) 1143 (64.2) <0.001
Family history 3575 (40.0) 3046 (42.5) 529 (29.8) <0.001
Current smoker 2137 (23.9) 1907 (26.6) 230 (13.0) <0.001
Framingham risk score
FRS risk, mean ± SD 14.4 ± 11.6 13.0 ± 9.6 20.0 ± 16.2 <0.001
Low (<10%), n (%) 4024 (45.0) 3476 (47.2) 646 (36.0) <0.001
Intermediate (10–20%), n (%) 2903 (32.5) 2537 (34.4) 457 (25.5)
High (>20%), n (%) 2013 (22.5) 1353 (18.4) 690 (38.5)
Indications for CCTA, n (%)
Chest pain 4555 (58.4) 3725 (58.8) 830 (56.7) 0.075
Typical 1516 (19.4) 1223 (19.3) 293 (19.8) 0.610
Atypical 2602 (33.3) 2130 (33.6) 472 (31.9)
Non-cardiac 1388(17.8) 1223 (19.3) 274 (18.5)
Dyspnoea, n (%) 3024 (40.7) 2426 (40.2) 598 (42.4) 0.075
....................................................................................................................................................................................................................
Table 2 Baseline CCTA characteristics stratified by age group (long-term cohort)
Overall cohort
(n58984)
<70 years
(n57198)
70 years
(n5 1786)
P-value
Degree of obstructive disease, n (%)
Normal CCTA 3526 (39.2) 3226 (44.8) 300 (16.8) <0.001
Non-obstructive 2734 (30.4) 2074 (28.8) 660 (37.0)
Obstructive disease 2724 (30.3) 1898 (26.4) 826 (46.2)
Number of vessel disease, n (%)
One-vessel 1435 (16.0) 1077 (15.0) 358 (20.0) <0.001
Two-vessel 659 (7.3) 444 (6.2) 215 (12.0)
Three-vessel/left main 630 (7.0) 377 (5.2) 253 (14.2)
Segment involvement score, n (%)
0 3526 (39.2) 3326 (44.8) 300 (16.8) <0.001
1–3 3393 (37.8) 2657 (36.9) 736 (41.2)
>_4 2065 (23.0) 1315 (18.3) 750 (42.0)
4 S.R. Gnanenthiran et al.
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groups (Supplementary data online, Table S6).
Discussion
The long-term prognostic role of CCTA in older populations has not
been previously reported. In the present study, we show for the first
time that patients aged >70 years with CCTA-identified obstructive
or non-obstructive CAD have increased long-term mortality and
MACE compared with age-matched patients with a normal CCTA.
Moreover, atherosclerotic disease burden measured by SIS also has
prognostic utility in this group, with increasing segment involvement
correlating with increasing mortality and MACE. Compared with
younger people, older people are less likely to have a normal CCTA
(16.8% vs. 44.8%, P< 0.001) and have a higher incidence of obstruct-
ive multivessel disease (26.2% vs. 11.4% P< 0.001). In the elderly, the
presence of any obstructive disease confers a poor prognosis but cat-
egorization into one-, two-, and three-vessel coronary stenosis does
not provide meaningful risk stratification. These results have import-
ant prognostic implications for cardiovascular disease (CVD) risk
stratification in the elderly in whom conventional CVD risk factors
and risk classification systems are poorly predictive. Greater utiliza-
tion of CCTA in older populations may reduce the delays to diagno-
sis and disparities in cardiovascular care experienced by this
cohort.10 Additionally, it is likely that CCTA results will guide the use
of secondary prevention strategies including statin use and/or referral
for coronary revascularization, although whether such measures im-
prove outcomes in older populations require further evaluation.
There is limited evidence regarding the prognostic role of CCTA
in older populations. Coronary artery calcium score (CACS) alone
has been validated in the elderly at long-term follow-up, with the
Rotterdam study11 demonstrating that coronary calcification is a
strong, independent predictor of CVD. Increasing calcium score was
Figure 2 Adjusted survival (long-term all-cause adjusted mortality) according to: (i) number of diseased vessels on CCTA and age group: (A) <70
years; (B) >_70 years; and (ii) segment involvement score: (C) <70 years; (D) >_70 years.
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associated with increased cardiovascular events (CACS 0–100: HR
1.0, 101–400: HR 1.4, 401–1000: HR 1.9, >1000: HR 2.5) and total
mortality (CACS 0–100: HR 1.0, 101–400: HR 2.0, 401–1000: HR
2.0, >1000: HR 2.3) in those >70 years old. In another study of 3570
patients aged over 70 years, CACS reclassified CVD risk in 40% of
patients, primarily by excluding low risk (CACS < 400) subjects with
multiple risk factors.12 The utility of CACS is nevertheless limited as
it does not reflect luminal obstruction or non-calcified plaque, which
is also an important adverse prognostic predictor.13 In a medium-
term analysis of the CONFIRM study, CCTA findings predicted mor-
tality at medium-term follow-up in patients >65 years.3 In a subgroup
of asymptomatic people, CCTA additionally provided prognostic
value beyond cardiac risk factors and CACS for the prediction of
MACE in older adults using net reclassification.14 However, the long-
term prognostic utility of CCTA identified obstructive and non-
obstructive disease in older populations has not previously been
described. In our study, we found that obstructive disease and greater
atherosclerotic plaque burden (SIS) in patients >70 years identified
by CCTA was predictive of prognosis in this group even after adjust-
ment for clinical risk factors. Concerns that increased coronary calci-
fication, which is more prevalent in the elderly,15 may degrade the
interpretability of CCTA results by obscuring the coronary lumen
and reducing test specificity7,16 did not prevent CCTA from improv-
ing risk stratification of those >70 years of age.
Although disease extent, and the presence of any stenotic coron-
ary disease was predictive of outcome, there was no incremental pre-
diction with increasing number of vessels stenosed in patients
>70 years, in contrast to findings in the younger age group. A prior
analysis of the CONFIRM cohort at medium-term (2.3 years) follow-
up3 demonstrated that patients >_65 years had a lower incremental
hazard of death with an increasing number of stenosed vessels than
did younger patients (two-vessel HR 2.46 vs. 4; three-vessel HR 3.10
vs. 6.19). The CASS (Coronary Artery Surgery Study) registry dem-
onstrated that increasing number of vessels stenosed was associated
with increasing mortality at long-term follow-up in middle aged
groups (mean age 51 years) receiving medical therapy who under-
went coronary angiography for evaluation of CAD,17 but our analysis
demonstrates for the first time that the prognostic role of number of
stenosed vessels diminishes in older populations. This diminished util-
ity of number of vessels stenosed may reflect the high rate of all-
cause mortality in this cohort, with normal CCTA patients still mani-
festing a 2.8% annual incidence of death. Additionally, the higher
prevalence of coronary calcification in elderly patients may decrease
the specificity of computed tomography coronary angiography
(CTCA) with regards to diagnosing the number of stenosed vessels
thus diminishing the discriminatory prognostic value of CTCA find-
ings classified according to the number of stenosed vessels.
The extent of atherosclerotic burden on CCTA as assessed by SIS
appears to be an important predictor of long-term prognosis in older
people. SIS is a direct marker of global atherosclerotic burden,
....................................................................................................................................................................................................................
Table 3 Mortality stratified by age group and CCTA result
Total cohort
(n5 8984)
P-valuea <70 years
(n5 7198)
P-valuea 70 years
(n5 1786)
P-valuea
All CCTA results, n (%) 878 (9.8) 434 (6.0) <0.001 444 (24.8) <0.001
Degree of obstruction, n (%)
Normal 168 (4.8) <0.001 121 (3.8) <0.001 47 (15.7) <0.001
Non-obstructive 291 (10.6) 142 (6.8) 149 (22.6)
Obstructive 419 (15.4) 171 (9.0) 248 (30.0)
Number of vessel disease, n (%)
One-vessel 167 (11.6) <0.001 77 (7.1) <0.001 90 (25.1) <0.001
Two-vessel 112 (17.0) 45 (10.1) 67 (31.2)
Three-vessel/left main 140 (22.2) 49 (13.0) 91 (36.0)
Segment involvement score, n (%)
0 168 (4.8) <0.001 121 (3.8) <0.001 47 (15.7) <0.001
1–3 335 (9.9) 171 (6.4) 164 (22.3)
>_4 375 (18.2) 142 (10.8) 233 (31.1)
aP-value for linear trend.
...................... .......................
.................................................................................................
Table 4 Long-term mortality (unadjusted) stratified
by CCTA results according to age groups
<70 years 70 years
HR 95% CI HR 95% CI
CAD severity
Normal CCTA (reference) 1.00 1.00
Non-obstructive vs. ref 1.89 1.48–2.40 1.58 1.13–2.19
Obstructive vs. ref 2.54 2.01–3.20 2.19 1.60–2.99
One-vessel vs. ref 2.00 1.50–2.66 1.78 1.26–2.56
Two-vessel vs. ref 2.88 2.05–2.06 2.25 1.55–3.26
Three-vessel/LM vs. ref 3.72 2.67–5.18 2.72 1.91–3.87
Segment involvement score
0 (reference) 1.00 1.00
1–3 vs. ref 1.77 1.40–2.23 1.55 1.12–2.14
>_4 vs. ref 3.09 2.43–3.94 2.28 1.67–3.12
6 S.R. Gnanenthiran et al.
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reflecting both calcified and non-calcified plaque. With increasing pla-
que, there is likely to be increasing vulnerability to plaque erosion or
rupture. This diffuseness of plaque may thus be a better predictor of
general health and mortality in older cohorts, when compared with
degree of stenosis which is a surrogate marker of atherosclerotic
burden and a predictor of late vessel revascularization/MACE. While
prior studies have demonstrated a robust relationship between the
extent of CAD as quantified by SIS on CCTA and cardiovascular
events at short- to medium-term follow-up,18,19 there are no data on
the long-term prognostic utility of SIS in elderly patients. In one retro-
spective study of patients aged >70 years, there was no association
between plaque segment score and CAD or likelihood of being
symptomatic with CAD at 2.9 year follow-up.20 The unique prognos-
tic role of SIS at long-term follow-up in the elderly is clinically import-
ant and suggests that the routine reporting of SIS needs to be
strongly considered in all subjects, including the elderly.
There are several limitations to our analysis. First, CONFIRM is a
prospective observational study reflecting real-world clinical practice,
rather than a randomized trial. Second, there is no information regard-
ing coronary revascularization, medical therapy, or lifestyle modifica-
tions that occurred after CCTA performance and it is therefore
unknown if these influenced outcomes. Third, the study did not assess
frailty, and therefore, the validity of these results in frail older popula-
tions with competing comorbidities remains uncertain. Data regarding
the functional significance of identified stenotic lesions and cause-
specific mortality were unavailable. MACE data were unfortunately
available in only a subset of patients, and the baseline characteristics
varied between those who did have MACE data available compared
with those who did not (Supplementary data online, Table S7).
Conclusion
The presence and extent of CAD is a meaningful stratifier of both long-
term mortality and MACE in both those aged <70 years and >_70 years
old. In older people, the presence of obstructive or non-obstructive dis-
ease still confers a poorer prognosis compared with patients with a
normal CCTA. In particular, assessment of diffuse atherosclerotic bur-
den remains a powerful prognostic predictor in older patients but cat-
egorization into one-vessel, two-vessel, and three-vessel coronary
stenosis does not provide meaningful risk stratification.
Supplementary data
Supplementary data are available at European Heart Journal - Cardiovascular
Imaging online.
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